TP53 and cancer: Another effect of adrenergic signaling that could be significantly involved in the cancer initiation stage is decreased p53 function, which occurs through β-arrestin-1-mediated AKT activation and Mdm2 phosphorylation and activation, leading to the nuclear export, ubiquitination, and degradation of the p53 tumor suppressor.